Taiwanese fertility diagnostics company, Inti Labs (a subsidiary of QuarkBio), came to us looking to launch their brand into the crowded US fertility-treatment market. Having launched their first product, MIRA™, in Taiwan and Japan, they remained relatively unknown in the US. They needed a unified brand identity to assert their independence from QuarkBio; show up and stand out in the international fertility space; speak to both B2B and B2C audiences; and ensure scalability for future product lineups. The challenge was to set guidelines that build and maintain brand identity while leaving room for creative exploration and unique campaigns in future asset development.
Working closely with internal stakeholders and using our comprehensive market research, we developed guidelines that informed distinct visual elements and compelling brand communication strategies. These guidelines included:
It was important that the brand guidelines not only meet Inti Lab’s current needs but be able to inform their visual identity and messaging as the company grows and expands in both their product offering and international markets.
We provided Inti Labs with a coherent process for internal stakeholders when developing assets. This process, or these brand guidelines, saved time and budget knowing that primary brand decisions were made with their initial investment which allowed them to work with multiple agencies in multiple markets while maintaining consistency. Some examples of this include: